4-(Alkylthio)- and 4-(Arylthio)-Benzonitrile Derivatives as Androgen Receptor Antagonists for the Topical Suppression of Sebum Production

    Lorna Helen Mitchell, Zhi Wang, Lain-Yen Hu, Catherine R. Kostlan, Matthew Carroll, Danielle Dettling, Daniel K. Du, David Pocalyko, Kimberly Jane Wade
    Image of study
    TLDR Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.
    In 2009, researchers synthesized 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives, which are androgen receptor antagonists, and tested them for their ability to reduce sebum production. The androgen receptor activates genes involved in acne and alopecia, and its antagonists can potentially suppress sebum production, associated with acne vulgaris. The compounds were tested on five male Syrian hamsters aged 9-10 weeks, twice daily for 2 weeks. The results showed a moderate reduction in sebum production, suggesting potential use for these compounds in the topical treatment of conditions like acne and alopecia.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results

    Related Community Posts Join

    6 / 1000+ results
      If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      in Research  828 upvotes 5 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community Received Kintor’s KX-826 Today

      in Product  84 upvotes 5 months ago
      A user received Kintor’s KX-826/Pyrilutamide and shared initial impressions, noting concerns about the product's labeling and marketing. Other users discussed the legitimacy of the product, its effectiveness, and compared it to other treatments like Minoxidil and Finasteride.
      [object Object]

      community PYRILUTAMIDE PHASE 3 RESULTS : No statistical significance

      in Research/Science  127 upvotes 1 year ago
      The phase 3 trial results for Pyrilutamide showed no significant difference from the control treatment in increasing hair count, leading to the company halting its development. Users discussed their disappointment and skepticism about hair loss treatments, with some mentioning other treatments like Minoxidil, Finasteride, and RU58841.

      community It’s over. NOTHING has worked.

      in Chat  95 upvotes 2 years ago
      A user who has been trying various treatments for hair loss for four years, with no success. Suggestions include use of minoxidil, finasteride, RU58841, microneedling, supplements and multivitamins, lifestyle changes, scalp biopsy, and SMP.

    Related Research

    5 / 5 results